ABBV34:BVMF
Abbvie Inc BDR
R$90.50
arrow_upward
+0.42%(+0.37) 1D
Oct 13, 8:51:37 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV34...
Open
R$91.15
High
R$91.15
Low
R$83.00
Mkt. cap
484.83B
Avg. vol.
1.76K
Volume
407.00
52-wk high
R$91.15
52-wk low
R$58.27
Shares outstanding
1.77B
No. of employees
57K
Open
R$91.15
High
R$91.15
Low
R$83.00
Mkt. cap
484.83B
Avg. vol.
1.76K
Volume
407.00
52-wk high
R$91.15
52-wk low
R$58.27
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
6 hours ago
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Investing.com Canada
·
8 hours ago
AbbVie reports positive Crohn’s disease trial results for Skyrizi By Investing.com
BigGo Finance
·
10 hours ago
Paragon Labs Names Former Apogee CEO to Lead Company After AbbVie Deal
TipRanks
·
12 hours ago
AbbVie Targets Head and Neck Cancer With New Telisotuzumab Combo Trial
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Inc BDR
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com